main content start
GVOKE HypoPen is a prescription subcutaneous glucagon injection used to treat severe hypoglycemia in children and adults with diabetes ages 2 years and above. The product comes in a premixed ready-to-use pen and is administered in a two-step process with no visible needle. Gvoke should be stored at room temperature (68–77 degrees F) and is stable for 30 months (1 mg/0.2 mL dose) or two years (0.5 mg/0.1mL dose) from the date of manufacture. It is available in a one- or two-pack.
- Approved for ages 2+ with a prescription
- Subcutaneous glucagon injection
- Premixed ready-to-use pen, administered in a two-step process with no visible needle
- Store at room temperature, it’s stable for 30 months
- Dosage: 1 mg/0.2 mL dose or 2 years (0.5 mg/0.1 mL dose)
Gvoke HypoPen (glucagon injection) Specs
Key specification
Approved for Kids
2+
Ready to Use
Yes
Shelf Life
30 month(s)
Type
Injection Ready to Use
General Information
Product Name
Gvoke HypoPen (glucagon injection)
Product Type
Glucagon
Brand
Xeris Pharmaceuticals, Inc.
Other Devices & Supplies
Looking for a different way to manage diabetes care? Browse and compare information on the latest devices, tools, and technology.
